付纪军博士，副教授，博士生导师，主要研究方向为难溶性药物口服生物利用度、缓控释制剂和

纳米靶向制剂。在 Journal of Controlled Release、Acta Pharmaceutica Sinica B、Journal of Colloid and

Interface Science

等期刊上发表

SCI

论文二十余篇。主持完成国家自然科学基金一项。

1.Jiexia Li#; Lingmin Zhang#; Chengcheng Liu#; Qianni Wu; Songpei Li; Xueping Lei; Yugang Huang;

Guining Feng; Xiyong Yu; Xianqiang Sun; Zhaoming Guo*; Jijun Fu*; Doxorubicin-loaded hydrogen

peroxide self-providing copper nanodots for combination of chemotherapy and acid-induced chemodynamic

of drug-eluting microspheres for transcatheter arterial chemoembolization, Acta Biomaterialia, 2019, 88:

370-382.

4.Fu Jijun; Wu Bo; Wei Minyan; Huang Yugang; Zhou Yi; Zhang Qiang*; Du Lingran*; Prussian blue

nanosphere-embedded in situ hydrogel for photothermal therapy by peritumoral administration, Acta

Pharmaceutica Sinica B, 2019, 9(3): 604-614.

5.Ming-yue Chen#; Ze-kuan Xiao#; Xue-ping Lei#; Jie-xia Li; Xi-yong Yu; Jian-ye Zhang; Guo-dong

Ye; Yu-juan Guo; Guangquan Mo; Chu-wen Li; Yu Zhang; Ling-min Zhang*; Zhi-qiang Lin*; Ji-jun Fu*;

Preparation, characterization and in vitro – in vivo evaluation of bortezomib supermolecular aggregation

nanovehicles, Journal of Nanobiotechnology, 2020, 18(1): 57.

付纪军

性别

男

13268114376

邮箱

fujj@gzhmu.edu.cn